Athena Global Technologies Submits Q4 FY26 Compliance Certificate Under SEBI Regulation 74(5)

1 min read     Updated on 06 Apr 2026, 08:27 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Athena Global Technologies Limited has submitted its compliance certificate under SEBI Regulation 74(5) for Q4 FY26 to BSE Limited. The certificate, issued by RTA Bigshare Services Private Limited, confirms proper handling of dematerialisation processes during the quarter ended March 31, 2026. This represents mandatory regulatory compliance under SEBI (Depositories and Participants) Regulations, 2018, ensuring adherence to investor protection standards.

powered bylight_fuzz_icon
37033024

*this image is generated using AI for illustrative purposes only.

Athena Global Technologies Limited has filed its mandatory compliance certificate under SEBI Regulation 74(5) for the fourth quarter and year ended March 31, 2026. The submission was made to BSE Limited on April 6, 2026, fulfilling regulatory requirements under the SEBI (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Details

The compliance certificate was issued by Bigshare Services Private Limited, which serves as the company's Registrar and Transfer Agent (RTA). The certificate confirms that all securities received from Depository Participants for dematerialisation during the quarter ended March 31, 2026, were properly processed and confirmed to the depositories.

Parameter Details
Regulation SEBI Regulation 74(5)
Period Covered Q4 FY26 (Year ended March 31, 2026)
Filing Date April 6, 2026
RTA Bigshare Services Private Limited
Exchange BSE Limited
Scrip Code 517429

Certificate Confirmation

Bigshare Services Private Limited confirmed in their certificate dated April 4, 2026, that all dematerialisation processes were conducted in accordance with regulatory requirements. The RTA verified that:

  • Securities received for dematerialisation were confirmed (accepted/rejected) to depositories
  • All securities comprised in the certificates have been listed on the stock exchange
  • Security certificates received for dematerialisation were mutilated and cancelled after due verification
  • Depository names were substituted in the register of members as registered owners within the stipulated 15-day period

Company Information

Athena Global Technologies Limited, incorporated under CIN L74140TG1992PLC014182, is headquartered in Hyderabad, Telangana. The compliance submission was signed by M. Satyendra, Chairman & Managing Director (DIN: 01843557), confirming the company's adherence to regulatory obligations.

The filing represents routine compliance with SEBI regulations governing depositories and participants, ensuring transparency in the dematerialisation process and maintaining investor protection standards.

Historical Stock Returns for Athena Global Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
+0.78%+0.06%-9.81%-31.43%-28.44%+79.38%

What impact might any upcoming changes to SEBI's dematerialisation regulations have on Athena Global Technologies' compliance costs?

How could Athena Global Technologies' consistent regulatory compliance affect investor confidence and institutional investment interest?

Will Athena Global Technologies consider switching to a different Registrar and Transfer Agent to potentially reduce operational costs?

Athena Global Technologies
View Company Insights
View All News
like18
dislike

Athena Global Technologies Completes Healthcare Unit Acquisition and Divestment in Corporate Restructuring

2 min read     Updated on 01 Apr 2026, 07:08 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Athena Global Technologies Limited completed a corporate restructuring on March 31, 2026, involving the acquisition of 100% equity in MedleyMed Healthcare Solutions Private Limited for Rs. 10,000 and the divestment of Medley Medical Solutions Private Limited for Rs. 1.25 crores. Both related party transactions were conducted at arm's length to consolidate the group's healthcare and trading operations under one entity.

powered bylight_fuzz_icon
36553085

*this image is generated using AI for illustrative purposes only.

Athena Global Technologies Limited has announced the completion of a strategic corporate restructuring involving the acquisition and divestment of healthcare subsidiaries. The board of directors approved these transactions during their meeting held on March 31, 2026, aimed at consolidating the group's healthcare and trading operations.

Acquisition Details

The company has acquired 100% equity shareholding of MedleyMed Healthcare Solutions Private Limited, converting it into a wholly owned subsidiary. The acquisition represents a strategic move to strengthen the company's position in healthcare logistics and pharmaceutical trading operations.

Parameter: Details
Target Company: MedleyMed Healthcare Solutions Private Limited
CIN: U24239TG2019PTC136763
Acquisition Cost: Rs. 10,000
Equity Stake: 100%
Transaction Type: Cash consideration
Completion Date: March 31, 2026

MedleyMed Healthcare Solutions, incorporated on November 14, 2019, specializes in healthcare logistics and pharmaceutical trading operations. The company operates as a small-scale unit and has shown varying financial performance over recent years.

Financial Performance of Acquired Entity

The target company's turnover history demonstrates significant fluctuations in business performance:

Financial Year: Turnover (Lakhs)
FY-2025: 44.18
FY-2024: 299.75
FY-2023: 299.95

Divestment Transaction

Simultaneously, Athena Global Technologies has divested its stake in Medley Medical Solutions Private Limited as part of the restructuring exercise. This divestment complements the acquisition strategy by streamlining the group's healthcare operations.

Parameter: Details
Divested Company: Medley Medical Solutions Private Limited
CIN: U93000TG2016PTC111660
Sale Consideration: Rs. 1,25,33,689
Buyer: MedleyMed Healthcare Solutions Private Limited
Expected Completion: March 31, 2026

Financial Impact and Contribution

The divested entity's contribution to the consolidated financials as of September 30, 2025, was relatively modest:

  • Income Contribution: 0.17% of total consolidation income (0.94 lakhs)
  • Net Worth Contribution: 0.39% of total consolidation net worth (55.95 lakhs)

Regulatory Compliance and Structure

Both transactions qualify as related party transactions conducted at arm's length basis. The acquisition requires no specific government approvals beyond standard compliance under the Companies Act, 2013 and SEBI regulations. The restructuring aims to consolidate group healthcare and trading businesses under one entity for improved operational efficiency.

The board meeting commenced at 6:30 PM and concluded at 7:15 PM on March 31, 2026, with all necessary approvals obtained for both transactions. These strategic moves reflect the company's commitment to optimizing its healthcare business portfolio through focused consolidation.

Historical Stock Returns for Athena Global Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
+0.78%+0.06%-9.81%-31.43%-28.44%+79.38%

How will Athena Global Technologies address the significant revenue decline in MedleyMed Healthcare Solutions from Rs. 299.75 lakhs in FY-2024 to Rs. 44.18 lakhs in FY-2025?

What synergies does Athena expect to achieve by consolidating its healthcare operations, and what is the projected timeline for operational integration?

Will this restructuring lead to further acquisitions in the healthcare logistics sector or expansion into new pharmaceutical trading markets?

Athena Global Technologies
View Company Insights
View All News
like15
dislike

More News on Athena Global Technologies

1 Year Returns:-28.44%